CD274 and neoplasm: A higher frequency of circulating PD-1+ NK cells (mean > 9%) was associated with a better overall survival (OS) in patients with head and neck cancers (HNCs) (33), which indicates that PD-1+ NK cells are not necessarily inactive in PD-L1+ tumors but may only be inhibited from killing tumor cells.